Oxaliplatin and Bortezomib in Treating Patients With Advanced Cancer

This study has been terminated.

(Administratively complete.)

Sponsor:

ClinicalTrials.gov Identifier:

NCT00066625

First Posted: August 7, 2003

Last Update Posted: February 1, 2013

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

Information provided by (Responsible Party):

National Cancer Institute (NCI)

Study Status:	This study has been terminated.
Study Completion Date:	No date given
Primary Completion Date:	April 2007 (Final data collection date for primary outcome measure)

Study Status:

This study has been terminated.

Study Completion Date:

No date given

Primary Completion Date:

April 2007 (Final data collection date for primary outcome measure)